Collaborative Drug Discovery Awarded $1.5M Phase 2 SBIR Grant

Collaborative Drug Discovery received a $1.5M Phase 2 SBIR grant to develop their Bioassay Ontology Annotator software. A prototype of this software was successfully developed by CDD using a previously awarded Phase I SBIR grant.

The Bioassay Ontology Annotator, a tool to quickly annotate bioassay data, will be the foundation for a collaborative CDD electronic laboratory notebook (ELN). "With this grant we can now build automated annotation technologies into our platform that will advance the utility of applications like ELNs for secure collaboration and analyses.” said Barry A. Bunin, PhD, CDD CEO.



Be the first to comment

Or sign in with email

    Please check your e-mail for a link to activate your account.